A study found that low-dose naltrexone (LDN) does not provide pain relief for fibromyalgia. The researchers conducted a randomized controlled trial and found that LDN did not significantly reduce pain compared to a placebo. The study included 80 participants with fibromyalgia and lasted for 12 weeks. Overall, the findings suggest that LDN may not be an effective treatment for fibromyalgia-related pain. The results are important for healthcare providers and individuals with fibromyalgia seeking alternative treatments. The study highlights the need for further research into effective pain management strategies for fibromyalgia.
Source link
No role of Low-Dose Naltrexone for Pain Relief in Fibromyalgia
